Clermont-Ferrand, France, June 10, 2015 - CARBIOS (NYSE Alternext in Paris: ALCRB), an innovative green chemistry company specializing in breakthrough technologies dedicated to the recovery of plastic waste and the production of bio-polymers, today announced its participation in the second French Life Science Days conference which will take place in New York City on June 17th and 18th.
The French Life Science Days conference is an initiative of France Biotech. The conference brings together French companies in the life sciences space that are publicly listed, and the North American investment communities. Following the success of the conference's first edition in 2014, France Biotech is facilitating the 2015 edition of the conference to once again offer SMEs (small and medium enterprises) a forum in which to present and promote their activities to specialized investors in the United States.
In addition to CARBIOS, approximately twenty French companies in the biotech, medtech and cleantech spaces will participate in the French Life Science Days conference to meet specialized North American investors, financial analysts, other financial intermediaries and the press. This edition of the conference is expected to be broadly covered by the press in France and the United States.
French Life Science Days conference, June 17thand 18th, 2015
W Hotel, 541 Lexington Avenue, New York, NY 10022
About the «French Life Science Days»
This second edition aims at fostering and boosting the connections between French listed companies and investors worldwide in an effort to facilitate exchanges and demonstrate the solidity of our own financial community. This French Life Science Days initiative brings together key Parisian players (brokers, analysts, auditors, lawyers and communication agencies) to form a sponsorship committee that will support life sciences entrepreneurs. During this occasion, the French biotech companies listed on the NYSE Euronext exchange will introduce themselves to international investors.
About France Biotech
France Biotech brings together the main French life science companies and their expert partners. Its mission is to support the development of the French life sciences by advocating for a favorable regulatory and fiscal environment. In 2004, France Biotech successfully lobbied the French government to create a special fiscal status for innovative start-ups and continues to act as an advocate for the French innovative sector. The organization is currently chaired by Pierre-Olivier Goineau, Co-Founder of ERYTECH Pharma. France Biotech has over 150 members and its board of directors is composed of 17 entrepreneurs in the life sciences.
For more information: http www.france-biotech.org
About CARBIOS
CARBIOS is a young, innovative green chemistry company, whose mission is to find biological solutions to the environmental and sustainable development issues faced by industrial businesses today. CARBIOS acquired the rights to research that was conducted over a number of years by various public and private sector laboratories. By leveraging the unique properties of biological catalysts (enzymes), it has used this research as the foundation for developing innovative industrial bioprocesses that optimize the technical, economic and environmental performance of polymers (thermoplastic materials and synthetic or food-based fibers). The company has focused its efforts on a strategic application sector: plastics. CARBIOS' growth strategy is based on a clear business model of industrial value creation that targets attractive markets, develops innovative and competitive bioprocesses and licenses them to major industrial stakeholders for commercialization. CARBIOS benefits from the financial support of the leading European venture capital firm Truffle Capital. CARBIOS was founded in 2011 and has been funded, since its inception, by funds managed by the Holding Incubatrice Chimie Verte fund. CARBIOS was granted the label "Young Innovative Company" by Bpifrance (former OSEO) and is eligible for investments by private equity mutual funds (FCPIs). For more information, please visit www.carbios.fr
Help employers find you! Check out all the jobs and post your resume.
The French Life Science Days conference is an initiative of France Biotech. The conference brings together French companies in the life sciences space that are publicly listed, and the North American investment communities. Following the success of the conference's first edition in 2014, France Biotech is facilitating the 2015 edition of the conference to once again offer SMEs (small and medium enterprises) a forum in which to present and promote their activities to specialized investors in the United States.
In addition to CARBIOS, approximately twenty French companies in the biotech, medtech and cleantech spaces will participate in the French Life Science Days conference to meet specialized North American investors, financial analysts, other financial intermediaries and the press. This edition of the conference is expected to be broadly covered by the press in France and the United States.
French Life Science Days conference, June 17thand 18th, 2015
W Hotel, 541 Lexington Avenue, New York, NY 10022
About the «French Life Science Days»
This second edition aims at fostering and boosting the connections between French listed companies and investors worldwide in an effort to facilitate exchanges and demonstrate the solidity of our own financial community. This French Life Science Days initiative brings together key Parisian players (brokers, analysts, auditors, lawyers and communication agencies) to form a sponsorship committee that will support life sciences entrepreneurs. During this occasion, the French biotech companies listed on the NYSE Euronext exchange will introduce themselves to international investors.
About France Biotech
France Biotech brings together the main French life science companies and their expert partners. Its mission is to support the development of the French life sciences by advocating for a favorable regulatory and fiscal environment. In 2004, France Biotech successfully lobbied the French government to create a special fiscal status for innovative start-ups and continues to act as an advocate for the French innovative sector. The organization is currently chaired by Pierre-Olivier Goineau, Co-Founder of ERYTECH Pharma. France Biotech has over 150 members and its board of directors is composed of 17 entrepreneurs in the life sciences.
For more information: http www.france-biotech.org
About CARBIOS
CARBIOS is a young, innovative green chemistry company, whose mission is to find biological solutions to the environmental and sustainable development issues faced by industrial businesses today. CARBIOS acquired the rights to research that was conducted over a number of years by various public and private sector laboratories. By leveraging the unique properties of biological catalysts (enzymes), it has used this research as the foundation for developing innovative industrial bioprocesses that optimize the technical, economic and environmental performance of polymers (thermoplastic materials and synthetic or food-based fibers). The company has focused its efforts on a strategic application sector: plastics. CARBIOS' growth strategy is based on a clear business model of industrial value creation that targets attractive markets, develops innovative and competitive bioprocesses and licenses them to major industrial stakeholders for commercialization. CARBIOS benefits from the financial support of the leading European venture capital firm Truffle Capital. CARBIOS was founded in 2011 and has been funded, since its inception, by funds managed by the Holding Incubatrice Chimie Verte fund. CARBIOS was granted the label "Young Innovative Company" by Bpifrance (former OSEO) and is eligible for investments by private equity mutual funds (FCPIs). For more information, please visit www.carbios.fr
Help employers find you! Check out all the jobs and post your resume.
